Synonyms: 18F-AV-1451 | [F-18]T807 | flortaucipir F-18 | LY-3191748 | Tauvid®
flortaucipir (18F) is an approved drug (FDA (2020), EMA (2024))
Compound class:
Synthetic organic
Comment: Flortaucipir (18F) is an investigational PET imaging agent (diagnostic radiopharmaceutical) designed to visualise tau protein (MAPT; P10636) in Alzheimer's disease brains. Compare with the approved agent, florbetapir, used to visualise β-amyloid.
|
|
Bioactivity Comments |
Tau imaging with flortaucipir (18F) has been validated in postmortem tissue [1-2]. A dissociation constant (Kd) of 14.6 nM is reported for flortaucipir (18F) (a.k.a.[(18)F]T807) by measuring binding in brain sections from the frontal lobe of Alzheimer's disease patients [3]. Flortaucipir (18F) signal co-localises with β-amyloid, but does not bind to Aβ plaques. |
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|